Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lilly and Sigilon collaborate on encapsulated cell therapies for type 1 diabetes

April 5, 2018

FDA allows IND for phase Ib/IIa study of AG-019 for early onset type 1 diabetes

April 5, 2018

Rhythm acquires rights to Takeda GOAT inhibitor for Prader-Willi syndrome

April 4, 2018

Numerate patents novel FFAR4 agonists

April 3, 2018

Prometic Life Sciences offers new data from phase II study of PBI-4050 in Alstrom syndrome

March 29, 2018

Lanadelumab submissions in E.U. and Canada accepted for review

March 29, 2018

EMA accepts BioMarin's MAA for pegvaliase to treat adults with PKU

March 29, 2018

Semglee biosimilar insulin glargine approved in E.U. and Australia

March 28, 2018

Sichuan Kelun-Biotech Biopharmaceutical patents thrombopoietin receptor agonists

March 28, 2018

Japan's MHLW grants Sakigake designation to JR-141 for Hunter's syndrome

March 28, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...